SrasV1, Main, Exploration, bibRecordById, Pascal:05-0238636

Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus

Identifieur interne : 004E72 ( Main/Exploration ); précédent : 004E71; suivant : 004E73

Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus

Auteurs : Gerold Hoever [Allemagne] ; Lidia Baltina [Russie] ; Martin Michaelis [Allemagne] ; Rimma Kondratenko [Russie] ; Lia Baltina [Russie] ; Genrich A. Tolstikov [Russie] ; Hans W. Doerr [Allemagne] ; Jindrich Jr Cinatl [Allemagne]

Source :

Journal of medicinal chemistry : (Print) [ 0022-2623 ] ; 2005.

RBID : Pascal:05-0238636

Descripteurs français

KwdFr :
- Acide glycyrrhizique (), Acide glycyrrhizique (analogues et dérivés), Acide glycyrrhizique (pharmacologie), Acide glycyrrhizique (synthèse chimique), Animaux, Antiviraux (), Antiviraux (pharmacologie), Antiviraux (synthèse chimique), Cellules Vero, Relation structure-activité, Réplication virale (), Virus du SRAS (), Virus du SRAS (isolement et purification).
MESH :
- analogues et dérivés : Acide glycyrrhizique.
- isolement et purification : Virus du SRAS.
- pharmacologie : Acide glycyrrhizique, Antiviraux.
- synthèse chimique : Acide glycyrrhizique, Antiviraux.
Pascal (Inist)
- Acide glycyrrhizique, Animaux, Antiviraux, Cellules Vero, Relation structure activité, Relation structure-activité, Réplication virale, Synthèse chimique, Glycyrrhizique acide, Saponine, Oléanane dérivé, Acide uronique, Glycoside, Triterpène, Terpénoïde, Composé pentacyclique, Enone, Glycosylamine, Glycopeptide, Antiviral, Coronavirus, Syndrome respiratoire aigu sévère, In vitro, Virus du SRAS.

English descriptors

KwdEn :
- Animals, Antiviral, Antiviral Agents (chemical synthesis), Antiviral Agents (chemistry), Antiviral Agents (pharmacology), Chemical synthesis, Chlorocebus aethiops, Coronavirus, Enone, Glycopeptide, Glycoside, Glycosylamine, Glycyrrhizic Acid (analogs & derivatives), Glycyrrhizic Acid (chemical synthesis), Glycyrrhizic Acid (chemistry), Glycyrrhizic Acid (pharmacology), Glycyrrhizic acid, In vitro, Oleanane derivatives, Pentacyclic compound, SARS Virus (drug effects), SARS Virus (isolation & purification), Saponin, Severe acute respiratory syndrome, Structure activity relation, Structure-Activity Relationship, Terpenoid, Triterpene, Uronic acid, Vero Cells, Virus Replication (drug effects).
MESH :
- chemical , analogs & derivatives : Glycyrrhizic Acid.
- chemical , chemical synthesis : Antiviral Agents, Glycyrrhizic Acid.
- chemical , chemistry : Antiviral Agents, Glycyrrhizic Acid.
- chemical , pharmacology : Antiviral Agents, Glycyrrhizic Acid.
- drug effects : SARS Virus, Virus Replication.
- isolation & purification : SARS Virus.
- Animals, Chlorocebus aethiops, Structure-Activity Relationship, Vero Cells.

Abstract

Glycyrrhizin (GL) was shown to inhibit SARS-coronavirus (SARS-CoV) replication in vitro. Here the anti-SARS-CoV activity of 15 GL derivatives was tested. The introduction of 2-acetamido-β-D-glucopyranosylamine into the glycoside chain of GL resulted in 10-fold increased anti-SARS-CoV activity compared to GL. Amides of GL and conjugates of GL with two amino acid residues and a free 30-COOH function presented up to 70-fold increased activity against SARS-CoV but also increased cytotoxicity resulting in decreased selectivity index.

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus</title>
<author><name sortKey="Hoever, Gerold" sort="Hoever, Gerold" uniqKey="Hoever G" first="Gerold" last="Hoever">Gerold Hoever</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Institute of Medical Virology, Johann Wolfgang Goethe University Frankfurt, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Baltina, Lidia" sort="Baltina, Lidia" uniqKey="Baltina L" first="Lidia" last="Baltina">Lidia Baltina</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute of Organic Chemistry, Ufa Research Centre of Russian Academy of Sciences, Prospect Oktyabrya, 71</s1>
<s2>450054, Ufa</s2>
<s3>RUS</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Russie</country>
<wicri:noRegion>450054, Ufa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Michaelis, Martin" sort="Michaelis, Martin" uniqKey="Michaelis M" first="Martin" last="Michaelis">Martin Michaelis</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Institute of Medical Virology, Johann Wolfgang Goethe University Frankfurt, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kondratenko, Rimma" sort="Kondratenko, Rimma" uniqKey="Kondratenko R" first="Rimma" last="Kondratenko">Rimma Kondratenko</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute of Organic Chemistry, Ufa Research Centre of Russian Academy of Sciences, Prospect Oktyabrya, 71</s1>
<s2>450054, Ufa</s2>
<s3>RUS</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Russie</country>
<wicri:noRegion>450054, Ufa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Baltina, Lia" sort="Baltina, Lia" uniqKey="Baltina L" first="Lia" last="Baltina">Lia Baltina</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute of Organic Chemistry, Ufa Research Centre of Russian Academy of Sciences, Prospect Oktyabrya, 71</s1>
<s2>450054, Ufa</s2>
<s3>RUS</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Russie</country>
<wicri:noRegion>450054, Ufa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tolstikov, Genrich A" sort="Tolstikov, Genrich A" uniqKey="Tolstikov G" first="Genrich A." last="Tolstikov">Genrich A. Tolstikov</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute of Organic Chemistry, Ufa Research Centre of Russian Academy of Sciences, Prospect Oktyabrya, 71</s1>
<s2>450054, Ufa</s2>
<s3>RUS</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Russie</country>
<wicri:noRegion>450054, Ufa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Doerr, Hans W" sort="Doerr, Hans W" uniqKey="Doerr H" first="Hans W." last="Doerr">Hans W. Doerr</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Institute of Medical Virology, Johann Wolfgang Goethe University Frankfurt, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cinatl, Jindrich Jr" sort="Cinatl, Jindrich Jr" uniqKey="Cinatl J" first="Jindrich Jr" last="Cinatl">Jindrich Jr Cinatl</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Institute of Medical Virology, Johann Wolfgang Goethe University Frankfurt, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">05-0238636</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0238636 INIST</idno>
<idno type="RBID">Pascal:05-0238636</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000680</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000310</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000703</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000703</idno>
<idno type="wicri:doubleKey">0022-2623:2005:Hoever G:antiviral:activity:of</idno>
<idno type="wicri:Area/Main/Merge">005223</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15715493</idno>
<idno type="wicri:Area/PubMed/Corpus">002881</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002881</idno>
<idno type="wicri:Area/PubMed/Curation">002881</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002881</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002823</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002823</idno>
<idno type="wicri:Area/Ncbi/Merge">000D91</idno>
<idno type="wicri:Area/Ncbi/Curation">000D91</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000D91</idno>
<idno type="wicri:doubleKey">0022-2623:2005:Hoever G:antiviral:activity:of</idno>
<idno type="wicri:Area/Main/Merge">004C47</idno>
<idno type="wicri:Area/Main/Curation">004E72</idno>
<idno type="wicri:Area/Main/Exploration">004E72</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus</title>
<author><name sortKey="Hoever, Gerold" sort="Hoever, Gerold" uniqKey="Hoever G" first="Gerold" last="Hoever">Gerold Hoever</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Institute of Medical Virology, Johann Wolfgang Goethe University Frankfurt, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Baltina, Lidia" sort="Baltina, Lidia" uniqKey="Baltina L" first="Lidia" last="Baltina">Lidia Baltina</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute of Organic Chemistry, Ufa Research Centre of Russian Academy of Sciences, Prospect Oktyabrya, 71</s1>
<s2>450054, Ufa</s2>
<s3>RUS</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Russie</country>
<wicri:noRegion>450054, Ufa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Michaelis, Martin" sort="Michaelis, Martin" uniqKey="Michaelis M" first="Martin" last="Michaelis">Martin Michaelis</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Institute of Medical Virology, Johann Wolfgang Goethe University Frankfurt, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kondratenko, Rimma" sort="Kondratenko, Rimma" uniqKey="Kondratenko R" first="Rimma" last="Kondratenko">Rimma Kondratenko</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute of Organic Chemistry, Ufa Research Centre of Russian Academy of Sciences, Prospect Oktyabrya, 71</s1>
<s2>450054, Ufa</s2>
<s3>RUS</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Russie</country>
<wicri:noRegion>450054, Ufa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Baltina, Lia" sort="Baltina, Lia" uniqKey="Baltina L" first="Lia" last="Baltina">Lia Baltina</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute of Organic Chemistry, Ufa Research Centre of Russian Academy of Sciences, Prospect Oktyabrya, 71</s1>
<s2>450054, Ufa</s2>
<s3>RUS</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Russie</country>
<wicri:noRegion>450054, Ufa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tolstikov, Genrich A" sort="Tolstikov, Genrich A" uniqKey="Tolstikov G" first="Genrich A." last="Tolstikov">Genrich A. Tolstikov</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute of Organic Chemistry, Ufa Research Centre of Russian Academy of Sciences, Prospect Oktyabrya, 71</s1>
<s2>450054, Ufa</s2>
<s3>RUS</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Russie</country>
<wicri:noRegion>450054, Ufa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Doerr, Hans W" sort="Doerr, Hans W" uniqKey="Doerr H" first="Hans W." last="Doerr">Hans W. Doerr</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Institute of Medical Virology, Johann Wolfgang Goethe University Frankfurt, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cinatl, Jindrich Jr" sort="Cinatl, Jindrich Jr" uniqKey="Cinatl J" first="Jindrich Jr" last="Cinatl">Jindrich Jr Cinatl</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Institute of Medical Virology, Johann Wolfgang Goethe University Frankfurt, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of medicinal chemistry : (Print)</title>
<title level="j" type="abbreviated">J. med. chem. : (Print)</title>
<idno type="ISSN">0022-2623</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of medicinal chemistry : (Print)</title>
<title level="j" type="abbreviated">J. med. chem. : (Print)</title>
<idno type="ISSN">0022-2623</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antiviral</term>
<term>Antiviral Agents (chemical synthesis)</term>
<term>Antiviral Agents (chemistry)</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Chemical synthesis</term>
<term>Chlorocebus aethiops</term>
<term>Coronavirus</term>
<term>Enone</term>
<term>Glycopeptide</term>
<term>Glycoside</term>
<term>Glycosylamine</term>
<term>Glycyrrhizic Acid (analogs & derivatives)</term>
<term>Glycyrrhizic Acid (chemical synthesis)</term>
<term>Glycyrrhizic Acid (chemistry)</term>
<term>Glycyrrhizic Acid (pharmacology)</term>
<term>Glycyrrhizic acid</term>
<term>In vitro</term>
<term>Oleanane derivatives</term>
<term>Pentacyclic compound</term>
<term>SARS Virus (drug effects)</term>
<term>SARS Virus (isolation & purification)</term>
<term>Saponin</term>
<term>Severe acute respiratory syndrome</term>
<term>Structure activity relation</term>
<term>Structure-Activity Relationship</term>
<term>Terpenoid</term>
<term>Triterpene</term>
<term>Uronic acid</term>
<term>Vero Cells</term>
<term>Virus Replication (drug effects)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Acide glycyrrhizique ()</term>
<term>Acide glycyrrhizique (analogues et dérivés)</term>
<term>Acide glycyrrhizique (pharmacologie)</term>
<term>Acide glycyrrhizique (synthèse chimique)</term>
<term>Animaux</term>
<term>Antiviraux ()</term>
<term>Antiviraux (pharmacologie)</term>
<term>Antiviraux (synthèse chimique)</term>
<term>Cellules Vero</term>
<term>Relation structure-activité</term>
<term>Réplication virale ()</term>
<term>Virus du SRAS ()</term>
<term>Virus du SRAS (isolement et purification)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Glycyrrhizic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Antiviral Agents</term>
<term>Glycyrrhizic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antiviral Agents</term>
<term>Glycyrrhizic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term>
<term>Glycyrrhizic Acid</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Acide glycyrrhizique</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>SARS Virus</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Acide glycyrrhizique</term>
<term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Acide glycyrrhizique</term>
<term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Chlorocebus aethiops</term>
<term>Structure-Activity Relationship</term>
<term>Vero Cells</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Acide glycyrrhizique</term>
<term>Animaux</term>
<term>Antiviraux</term>
<term>Cellules Vero</term>
<term>Relation structure activité</term>
<term>Relation structure-activité</term>
<term>Réplication virale</term>
<term>Synthèse chimique</term>
<term>Glycyrrhizique acide</term>
<term>Saponine</term>
<term>Oléanane dérivé</term>
<term>Acide uronique</term>
<term>Glycoside</term>
<term>Triterpène</term>
<term>Terpénoïde</term>
<term>Composé pentacyclique</term>
<term>Enone</term>
<term>Glycosylamine</term>
<term>Glycopeptide</term>
<term>Antiviral</term>
<term>Coronavirus</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>In vitro</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Glycyrrhizin (GL) was shown to inhibit SARS-coronavirus (SARS-CoV) replication in vitro. Here the anti-SARS-CoV activity of 15 GL derivatives was tested. The introduction of 2-acetamido-β-D-glucopyranosylamine into the glycoside chain of GL resulted in 10-fold increased anti-SARS-CoV activity compared to GL. Amides of GL and conjugates of GL with two amino acid residues and a free 30-COOH function presented up to 70-fold increased activity against SARS-CoV but also increased cytotoxicity resulting in decreased selectivity index.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
<li>Russie</li>
</country>
<region><li>District de Darmstadt</li>
<li>Hesse (Land)</li>
</region>
<settlement><li>Francfort-sur-le-Main</li>
</settlement>
</list>
<tree><country name="Allemagne"><region name="Hesse (Land)"><name sortKey="Hoever, Gerold" sort="Hoever, Gerold" uniqKey="Hoever G" first="Gerold" last="Hoever">Gerold Hoever</name>
</region>
<name sortKey="Cinatl, Jindrich Jr" sort="Cinatl, Jindrich Jr" uniqKey="Cinatl J" first="Jindrich Jr" last="Cinatl">Jindrich Jr Cinatl</name>
<name sortKey="Doerr, Hans W" sort="Doerr, Hans W" uniqKey="Doerr H" first="Hans W." last="Doerr">Hans W. Doerr</name>
<name sortKey="Michaelis, Martin" sort="Michaelis, Martin" uniqKey="Michaelis M" first="Martin" last="Michaelis">Martin Michaelis</name>
</country>
<country name="Russie"><noRegion><name sortKey="Baltina, Lidia" sort="Baltina, Lidia" uniqKey="Baltina L" first="Lidia" last="Baltina">Lidia Baltina</name>
</noRegion>
<name sortKey="Baltina, Lia" sort="Baltina, Lia" uniqKey="Baltina L" first="Lia" last="Baltina">Lia Baltina</name>
<name sortKey="Kondratenko, Rimma" sort="Kondratenko, Rimma" uniqKey="Kondratenko R" first="Rimma" last="Kondratenko">Rimma Kondratenko</name>
<name sortKey="Tolstikov, Genrich A" sort="Tolstikov, Genrich A" uniqKey="Tolstikov G" first="Genrich A." last="Tolstikov">Genrich A. Tolstikov</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004E72 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004E72 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:05-0238636
   |texte=   Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

Serveur d'exploration SRAS

Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus

Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.